Logo image of ATLN

ATLANTIC INTERNATIONAL CORP (ATLN) Stock Fundamental Analysis

NASDAQ:ATLN - US0485921094 - Common Stock

3.9 USD
-0.06 (-1.52%)
Last: 9/2/2025, 8:00:00 PM
Fundamental Rating

2

Taking everything into account, ATLN scores 2 out of 10 in our fundamental rating. ATLN was compared to 55 industry peers in the Life Sciences Tools & Services industry. ATLN has a bad profitability rating. Also its financial health evaluation is rather negative. ATLN is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year ATLN has reported negative net income.
In the past year ATLN had a positive cash flow from operations.
ATLN had negative earnings in each of the past 5 years.
ATLN had a negative operating cash flow in each of the past 5 years.
ATLN Yearly Net Income VS EBIT VS OCF VS FCFATLN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

With a Return On Assets value of -91.01%, ATLN is not doing good in the industry: 92.73% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -91.01%
ROE N/A
ROIC N/A
ROA(3y)-95.29%
ROA(5y)-94.51%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ATLN Yearly ROA, ROE, ROICATLN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 1K

1.3 Margins

With a Gross Margin value of 10.79%, ATLN is not doing good in the industry: 87.27% of the companies in the same industry are doing better.
ATLN's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ATLN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 10.8%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-47.23%
GM growth 5Y-28.86%
ATLN Yearly Profit, Operating, Gross MarginsATLN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K -4K -5K

More info and screens

2

2. Health

2.1 Basic Checks

ATLN does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, ATLN has more shares outstanding
The number of shares outstanding for ATLN has been increased compared to 5 years ago.
The debt/assets ratio for ATLN is higher compared to a year ago.
ATLN Yearly Shares OutstandingATLN Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
ATLN Yearly Total Debt VS Total AssetsATLN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

ATLN has an Altman-Z score of 2.44. This is not the best score and indicates that ATLN is in the grey zone with still only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.44, ATLN is doing good in the industry, outperforming 63.64% of the companies in the same industry.
ATLN has a debt to FCF ratio of 23.54. This is a negative value and a sign of low solvency as ATLN would need 23.54 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 23.54, ATLN is in line with its industry, outperforming 54.55% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 23.54
Altman-Z 2.44
ROIC/WACCN/A
WACC11.68%
ATLN Yearly LT Debt VS Equity VS FCFATLN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

ATLN has a Current Ratio of 1.31. This is a normal value and indicates that ATLN is financially healthy and should not expect problems in meeting its short term obligations.
ATLN's Current ratio of 1.31 is on the low side compared to the rest of the industry. ATLN is outperformed by 80.00% of its industry peers.
A Quick Ratio of 1.31 indicates that ATLN should not have too much problems paying its short term obligations.
ATLN has a Quick ratio of 1.31. This is in the lower half of the industry: ATLN underperforms 70.91% of its industry peers.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 1.31
ATLN Yearly Current Assets VS Current LiabilitesATLN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 77.53% over the past year.
Looking at the last year, ATLN shows a very strong growth in Revenue. The Revenue has grown by 115.85%.
ATLN shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 284.02% yearly.
EPS 1Y (TTM)77.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%89.95%
Revenue 1Y (TTM)115.85%
Revenue growth 3Y1182.14%
Revenue growth 5Y284.02%
Sales Q2Q%-1.66%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y21.88%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ATLN Yearly Revenue VS EstimatesATLN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2024 2025 100M 200M 300M 400M
ATLN Yearly EPS VS EstimatesATLN Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 -5 -10 -15

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ATLN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ATLN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ATLN Price Earnings VS Forward Price EarningsATLN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of ATLN is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 71.12
EV/EBITDA N/A
ATLN Per share dataATLN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ATLN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ATLANTIC INTERNATIONAL CORP

NASDAQ:ATLN (9/2/2025, 8:00:00 PM)

3.9

-0.06 (-1.52%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.94%
Inst Owner Change108.62%
Ins Owners35.89%
Ins Owner Change-4.17%
Market Cap227.68M
Analysts82.86
Price TargetN/A
Short Float %4.44%
Short Ratio3.48
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.51
P/FCF 71.12
P/OCF 69.64
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-1.96
EYN/A
EPS(NY)-0.51
Fwd EYN/A
FCF(TTM)0.05
FCFY1.41%
OCF(TTM)0.06
OCFY1.44%
SpS7.59
BVpS-0.32
TBVpS-0.81
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -91.01%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 10.8%
FCFM 0.72%
ROA(3y)-95.29%
ROA(5y)-94.51%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-47.23%
GM growth 5Y-28.86%
F-Score5
Asset Turnover4.15
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 23.54
Debt/EBITDA N/A
Cap/Depr 1.38%
Cap/Sales 0.02%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.31
Quick Ratio 1.31
Altman-Z 2.44
F-Score5
WACC11.68%
ROIC/WACCN/A
Cap/Depr(3y)29.06%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)77.53%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%89.95%
EPS Next Y21.88%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)115.85%
Revenue growth 3Y1182.14%
Revenue growth 5Y284.02%
Sales Q2Q%-1.66%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-154.81%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y168.74%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y171.33%
OCF growth 3YN/A
OCF growth 5YN/A